Junya Ito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Junya Ito has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Kiyotaka Nakagawa
Laboratory of Food Function Analysis, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan
11 shared publications - Naoki Shimizu
Food and Biodynamic Chemistry Laboratory, Graduate School of Agricultural Science, Tohoku University, Sendai, Miyagi 980-8572, Japan
4 shared publications - Soo Takasu
Gifu Pharmaceutical University
3 shared publications - Teruo Miyazawa
Food and Biotechnology Innovation Project, New Industry Creation Hatchery Center (NICHe), Tohoku University, Sendai, Miyagi 980-8579, Japan
3 shared publications - Eikan Mishima
Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, Japan
2 shared publications - Eri Kobayashi
Food and Biodynamic Chemistry Laboratory, Graduate School of Agricultural Science, Tohoku University, Sendai, Miyagi 980-8572, Japan
2 shared publications
Latest Publications
- Open Access
- 25 January 2026
- Published by Elsevier in Toxicology
- Vol. 522
Arsenite sensitizes to ferroptosis by disrupting selenium metabolism and reducing GPx4 expression
- 25 January 2026
- Published by Elsevier in Toxicology
- Vol. 522
Open AccessArsenite sensitizes to ferroptosis by disrupting selenium metabolism and reducing GPx4 expression
- Open Access
- 22 July 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (30) , 8349-8352
Synthesis of Citrifurans A and D through Assembly of the Natural Products Citrinin and Gregatin A
The synthesis of citrifuran A, a structurally unique natural heterodimer, was accomplished in a bioinspired manner by a thermal [4 + 2] cycloaddition between citrinin and gregatin A, the former of which was synthesized via a Diels-Alder-initiated aromatization reaction and the latter via a Cu-mediated 5-endo cyclization-bromination as the key steps, respectively. On the other hand, an acid/base-promoted cycloaddition of citrinin with gregatin A followed by hydrolysis of the resulting intermediate furnished citrifuran D.
- 22 July 2025
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 27 (30) , 8349-8352
Open AccessSynthesis of Citrifurans A and D through Assembly of the Natural Products Citrinin and Gregatin A
The synthesis of citrifuran A, a structurally unique natural heterodimer, was accomplished in a bioinspired manner by a thermal [4 + 2] cycloaddition between citrinin and gregatin A, the former of which was synthesized via a Diels-Alder-initiated aromatization reaction and the latter via a Cu-mediated 5-endo cyclization-bromination as the key steps, respectively. On the other hand, an acid/base-promoted cycloaddition of citrinin with gregatin A followed by hydrolysis of the resulting intermediate furnished citrifuran D.
- 1 January 2025
- Published by Science Exploration Press in Ferroptosis and Oxidative Stress
The role of redoxins in ferroptosis
Redoxins, oxidoreductases of the thioredoxin (Trx) family, are important regulators of signaling processes. The Trx family is characterized by the Trx fold consisting of a four-stranded β-sheet surrounded by three-four α-helices. This article mainly focuses on mammalian Trxs, glutaredoxins, and peroxiredoxins, herein referred to as redoxins. This review article summarizes the current knowledge on redoxin-driven processes related to ferroptosis, a non-apoptotic cell death mechanism based on uncontrolled oxidation of polyunsaturated fatty acids in membranes. To a great extent, the formation of these lipid hydroperoxides depend on the non-enzymatic formation of hydroxyl radicals, the product of the Fenton reaction between hydrogen peroxide and redox active iron. Redoxins are regulators of both redox and iron homeostasis, and some redoxins use lipid hydroperoxides directly as substrates. This review article aims to increase the recognition of redoxins as potential regulators of ferroptosis in both physiological and pathological conditions, while also promoting research to address the numerous gaps in cell specificity and the molecular mechanisms influencing ferroptotic pathways.
- 1 January 2025
- Published by Science Exploration Press in Ferroptosis and Oxidative Stress
The role of redoxins in ferroptosis
Redoxins, oxidoreductases of the thioredoxin (Trx) family, are important regulators of signaling processes. The Trx family is characterized by the Trx fold consisting of a four-stranded β-sheet surrounded by three-four α-helices. This article mainly focuses on mammalian Trxs, glutaredoxins, and peroxiredoxins, herein referred to as redoxins. This review article summarizes the current knowledge on redoxin-driven processes related to ferroptosis, a non-apoptotic cell death mechanism based on uncontrolled oxidation of polyunsaturated fatty acids in membranes. To a great extent, the formation of these lipid hydroperoxides depend on the non-enzymatic formation of hydroxyl radicals, the product of the Fenton reaction between hydrogen peroxide and redox active iron. Redoxins are regulators of both redox and iron homeostasis, and some redoxins use lipid hydroperoxides directly as substrates. This review article aims to increase the recognition of redoxins as potential regulators of ferroptosis in both physiological and pathological conditions, while also promoting research to address the numerous gaps in cell specificity and the molecular mechanisms influencing ferroptotic pathways.
- Open Access
- 9 July 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (13) , e23800
1‐Deoxynojirimycin attenuates pathological markers of Alzheimer's disease in the in vitro model of neuronal insulin resistance
Insulin resistance, the hallmark of type 2 diabetes mellitus (T2DM), has emerged as a pathological feature in Alzheimer's disease (AD). Given the shared role of insulin resistance in T2DM and AD, repurposing peripheral insulin sensitizers is a promising strategy to preserve neuronal insulin sensitivity and prevent AD. 1‐Deoxynojirimycin (DNJ), a bioactive iminosugar, exhibited insulin‐sensitizing effects in metabolic tissues and was detected in brain tissue post‐oral intake. However, its impact on brain and neuronal insulin signaling has not been described. Here, we investigated the effect of DNJ treatment on insulin signaling and AD markers in insulin‐resistant human SK‐N‐SH neuroblastoma, a cellular model of neuronal insulin resistance. Our findings show that DNJ increased the expression of insulin signaling genes and the phosphorylation status of key molecules implicated in insulin resistance (Y1146‐pIRβ, S473‐pAKT, S9‐GSK3B) while also elevating the expression of glucose transporters Glut3 and Glut4 , resulting in higher glucose uptake upon insulin stimuli. DNJ appeared to mitigate the insulin resistance‐driven increase in phosphorylated tau and Aβ 1‐42 levels by promoting insulin‐induced phosphorylation of GSK3B (a major tau kinase) and enhancing mRNA expression of the insulin‐degrading enzyme (IDE) pivotal for insulin and Aβ clearance. Overall, our study unveils probable mechanisms underlying the potential benefits of DNJ for AD, wherein DNJ attenuates tau and amyloid pathologies by reversing neuronal insulin resistance. This provides a scientific basis for expanding the use of DNJ‐containing products for neuroprotective purposes and prompts further research into compounds with similar mechanisms of action.
- 9 July 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (13) , e23800
Open Access1‐Deoxynojirimycin attenuates pathological markers of Alzheimer's disease in the in vitro model of neuronal insulin resistance
Insulin resistance, the hallmark of type 2 diabetes mellitus (T2DM), has emerged as a pathological feature in Alzheimer's disease (AD). Given the shared role of insulin resistance in T2DM and AD, repurposing peripheral insulin sensitizers is a promising strategy to preserve neuronal insulin sensitivity and prevent AD. 1‐Deoxynojirimycin (DNJ), a bioactive iminosugar, exhibited insulin‐sensitizing effects in metabolic tissues and was detected in brain tissue post‐oral intake. However, its impact on brain and neuronal insulin signaling has not been described. Here, we investigated the effect of DNJ treatment on insulin signaling and AD markers in insulin‐resistant human SK‐N‐SH neuroblastoma, a cellular model of neuronal insulin resistance. Our findings show that DNJ increased the expression of insulin signaling genes and the phosphorylation status of key molecules implicated in insulin resistance (Y1146‐pIRβ, S473‐pAKT, S9‐GSK3B) while also elevating the expression of glucose transporters Glut3 and Glut4 , resulting in higher glucose uptake upon insulin stimuli. DNJ appeared to mitigate the insulin resistance‐driven increase in phosphorylated tau and Aβ 1‐42 levels by promoting insulin‐induced phosphorylation of GSK3B (a major tau kinase) and enhancing mRNA expression of the insulin‐degrading enzyme (IDE) pivotal for insulin and Aβ clearance. Overall, our study unveils probable mechanisms underlying the potential benefits of DNJ for AD, wherein DNJ attenuates tau and amyloid pathologies by reversing neuronal insulin resistance. This provides a scientific basis for expanding the use of DNJ‐containing products for neuroprotective purposes and prompts further research into compounds with similar mechanisms of action.
- Open Access
PRDX6 dictates ferroptosis sensitivity by directing cellular selenium mobilization
Summary: Selenium-dependent glutathione peroxidase 4 (GPX4) is the guardian of ferroptosis and prevents unrestrained (phospho)lipid peroxidation by directly reducing phospholipid hydroperoxides (PLOOH) to their corresponding alcohols. However, it remains unclear whether other phospholipid peroxidases can also contribute to ferroptosis prevention, albeit to a varying degree. Here we show that cells lacking GPX4 still exhibit substantial PLOOH reduction capacity, arguing for the presence of alternative PLOOH peroxidases. By scrutinizing potential candidates, we showed that while overexpression of peroxiredoxin 6 (PRDX6), a thiol-specific antioxidant enzyme with reported PLOOH-reducing activity, failed to prevent ferroptosis, its genetic loss markedly sensitizes cancer cells to ferroptosis. Mechanistically, we uncover that PRDX6 facilitates intracellular selenium handling, which is crucial for selenium incorporation into selenoproteins, including GPX4. Consequently, PRDX6 modulates GPX4 expression, thereby dictating the sensitivity of cells to undergo ferroptosis. Our study highlights PRDX6 as a critical factor in ferroptosis prevention by directing cellular selenium mobilization.
Open AccessPRDX6 dictates ferroptosis sensitivity by directing cellular selenium mobilization
Summary: Selenium-dependent glutathione peroxidase 4 (GPX4) is the guardian of ferroptosis and prevents unrestrained (phospho)lipid peroxidation by directly reducing phospholipid hydroperoxides (PLOOH) to their corresponding alcohols. However, it remains unclear whether other phospholipid peroxidases can also contribute to ferroptosis prevention, albeit to a varying degree. Here we show that cells lacking GPX4 still exhibit substantial PLOOH reduction capacity, arguing for the presence of alternative PLOOH peroxidases. By scrutinizing potential candidates, we showed that while overexpression of peroxiredoxin 6 (PRDX6), a thiol-specific antioxidant enzyme with reported PLOOH-reducing activity, failed to prevent ferroptosis, its genetic loss markedly sensitizes cancer cells to ferroptosis. Mechanistically, we uncover that PRDX6 facilitates intracellular selenium handling, which is crucial for selenium incorporation into selenoproteins, including GPX4. Consequently, PRDX6 modulates GPX4 expression, thereby dictating the sensitivity of cells to undergo ferroptosis. Our study highlights PRDX6 as a critical factor in ferroptosis prevention by directing cellular selenium mobilization.
- Open Access
- 1 January 2024
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 49 (12) , 555-563
Impact of selenium content in fetal bovine serum on ferroptosis susceptibility and selenoprotein expression in cultured cells
Ferroptosis, a mode of cell death involving iron-dependent lipid peroxidation, has attracted widespread attention in the development of anticancer drugs and toxicological studies as a potential mechanism of chemical-induced cytotoxicity. This process is regulated by several antioxidant enzymes, of which the selenium-containing glutathione peroxidase 4 (GPx4) is the prime regulator. However, accurately and reproducibly evaluating ferroptosis in cultured cells is challenging since numerous experimental factors in in vitro setting can influence the results. In the present study, we found that the expression levels of selenoproteins, such as GPx4 and GPx1, fluctuate across several cell lines depending on the selenium content of different origin of fetal bovine serum (FBS). Cells cultured in FBS containing higher selenium concentrations exhibited elevated GPx4 expression, and were resistant to ferroptosis induced by erastin and RSL3. These findings suggest that the variability of selenium content in different FBS batches can significantly influence the susceptibility of cells to ferroptosis, highlighting the importance of standardizing these factors to enhance the reproducibility of ferroptosis-related experiments.
- 1 January 2024
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 49 (12) , 555-563
Open AccessImpact of selenium content in fetal bovine serum on ferroptosis susceptibility and selenoprotein expression in cultured cells
Ferroptosis, a mode of cell death involving iron-dependent lipid peroxidation, has attracted widespread attention in the development of anticancer drugs and toxicological studies as a potential mechanism of chemical-induced cytotoxicity. This process is regulated by several antioxidant enzymes, of which the selenium-containing glutathione peroxidase 4 (GPx4) is the prime regulator. However, accurately and reproducibly evaluating ferroptosis in cultured cells is challenging since numerous experimental factors in in vitro setting can influence the results. In the present study, we found that the expression levels of selenoproteins, such as GPx4 and GPx1, fluctuate across several cell lines depending on the selenium content of different origin of fetal bovine serum (FBS). Cells cultured in FBS containing higher selenium concentrations exhibited elevated GPx4 expression, and were resistant to ferroptosis induced by erastin and RSL3. These findings suggest that the variability of selenium content in different FBS batches can significantly influence the susceptibility of cells to ferroptosis, highlighting the importance of standardizing these factors to enhance the reproducibility of ferroptosis-related experiments.
- 22 December 2023
- Published by Elsevier in Food Research International
- Vol. 178, 113913
LC-MS/MS analysis of milk triacylglycerol hydroperoxide isomers which are generated corresponding to the photo- and thermal-oxidation
- 22 December 2023
- Published by Elsevier in Food Research International
- Vol. 178, 113913
LC-MS/MS analysis of milk triacylglycerol hydroperoxide isomers which are generated corresponding to the photo- and thermal-oxidation
- Open Access
- 17 September 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (11) , 102507
Coprinopsis cinerea dioxygenase is an oxygenase forming 10(S)-hydroperoxide of linoleic acid, essential for mushroom alcohol, 1-octen-3-ol, synthesis
- 17 September 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (11) , 102507
Open AccessCoprinopsis cinerea dioxygenase is an oxygenase forming 10(S)-hydroperoxide of linoleic acid, essential for mushroom alcohol, 1-octen-3-ol, synthesis
- Open Access
DHCR7 as a novel regulator of ferroptosis in hepatocytes
Recent evidence indicates that ferroptosis is implicated in the pathophysiology of various liver diseases; however, the mechanism of ferroptosis regulation in the liver is poorly understood. Here, using the whole-genome screening approach, we identified 7-dehydrocholesterol reductase (DHCR7), the terminal enzyme of cholesterol biosynthesis, as a novel regulator of ferroptosis in hepatocytes. Genetic and pharmacological inhibition (with AY9944) of DHCR7 suppressed lipid peroxidation and ferroptosis in human hepatocellular carcinoma Huh-7 cells. DHCR7 inhibition increased its substrate, 7-dehydrocholesterol (7-DHC), and extrinsic 7-DHC supplementation in turn suppressed ferroptosis. On the other hand, cholesterol deprivation had no effect on ferroptosis. A 7-DHC-derived oxysterol metabolite, 3β,5α-dihydroxycholest-7-en-6-one (DHCEO), was increased by a ferroptosis inducer RSL-3 in DHCR7-deficient cells, suggesting that the ferroptosis-suppressive effect of DHCR7 inhibition was driven by intracellular 7-DHC as a radical scavenger. While extrinsic 7-DHC supplementation suppressed ferroptosis in various cancer cells, pharmacological DHCR7 inhibition by AY9944 showed cell-type specific effects, which could be explained by high DHCR7 expression in Huh-7 cells. We further showed that AY9944 suppressed ferroptosis in murine primary hepatocytes in vitro and systemic administration of AY9944 inhibited hepatic ischemia-reperfusion injury in vivo . These findings provide new insights into the regulatory mechanism of liver ferroptosis and suggest that DHCR7 inhibition is a potential therapeutic option for ferroptosis-related liver diseases.
Open AccessDHCR7 as a novel regulator of ferroptosis in hepatocytes
Recent evidence indicates that ferroptosis is implicated in the pathophysiology of various liver diseases; however, the mechanism of ferroptosis regulation in the liver is poorly understood. Here, using the whole-genome screening approach, we identified 7-dehydrocholesterol reductase (DHCR7), the terminal enzyme of cholesterol biosynthesis, as a novel regulator of ferroptosis in hepatocytes. Genetic and pharmacological inhibition (with AY9944) of DHCR7 suppressed lipid peroxidation and ferroptosis in human hepatocellular carcinoma Huh-7 cells. DHCR7 inhibition increased its substrate, 7-dehydrocholesterol (7-DHC), and extrinsic 7-DHC supplementation in turn suppressed ferroptosis. On the other hand, cholesterol deprivation had no effect on ferroptosis. A 7-DHC-derived oxysterol metabolite, 3β,5α-dihydroxycholest-7-en-6-one (DHCEO), was increased by a ferroptosis inducer RSL-3 in DHCR7-deficient cells, suggesting that the ferroptosis-suppressive effect of DHCR7 inhibition was driven by intracellular 7-DHC as a radical scavenger. While extrinsic 7-DHC supplementation suppressed ferroptosis in various cancer cells, pharmacological DHCR7 inhibition by AY9944 showed cell-type specific effects, which could be explained by high DHCR7 expression in Huh-7 cells. We further showed that AY9944 suppressed ferroptosis in murine primary hepatocytes in vitro and systemic administration of AY9944 inhibited hepatic ischemia-reperfusion injury in vivo . These findings provide new insights into the regulatory mechanism of liver ferroptosis and suggest that DHCR7 inhibition is a potential therapeutic option for ferroptosis-related liver diseases.
- 17 March 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (12) , 5253-5257
Total Synthesis of the Broad-Spectrum Antibiotic Amycolamicin
The total synthesis of the antibiotic amycolamicin with a hybrid molecular architecture composed of five ring systems, which exhibits potent antibacterial activity against a wide range of drug-resistant bacteria, has been achieved in a convergent manner. A protecting-group-free intramolecular Diels–Alder reaction of a hydroxy tetraenal intermediate promoted by two equivalents of Et2AlCl, which proceeds highly diastereoselectively via an endo-equatorial transition state, has been utilized to construct the trans-decalin moiety of the molecule. The full structure of amycolamicin was assembled by a completely stereoconvergent N-acylation of a northern N-glycoside unit (α-anomer/β-anomer = 1:1.1) with a southern β-keto thioester segment followed by installation of the central tetramic acid moiety.
- 17 March 2022
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (12) , 5253-5257
Total Synthesis of the Broad-Spectrum Antibiotic Amycolamicin
The total synthesis of the antibiotic amycolamicin with a hybrid molecular architecture composed of five ring systems, which exhibits potent antibacterial activity against a wide range of drug-resistant bacteria, has been achieved in a convergent manner. A protecting-group-free intramolecular Diels–Alder reaction of a hydroxy tetraenal intermediate promoted by two equivalents of Et2AlCl, which proceeds highly diastereoselectively via an endo-equatorial transition state, has been utilized to construct the trans-decalin moiety of the molecule. The full structure of amycolamicin was assembled by a completely stereoconvergent N-acylation of a northern N-glycoside unit (α-anomer/β-anomer = 1:1.1) with a southern β-keto thioester segment followed by installation of the central tetramic acid moiety.